In supporting this view, a point mutation at the palmitoylation site of ERα (C451A-ERα), which is required for trafficking of the endogenous receptor to the plasma membrane [65], abolished membrane-bound ERα activity and impaired the neural responses of hypothalamic ERα neurons to hypoglycemia [66]. The gene discussed is ESR1; the disease is Hypoglycemia.